# Antiviral Therapy for Patients With Chronic Hepatitis B Infection

> **NCT05382351** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 238 (estimated)

## Conditions studied

- Chronic Hepatitis B Virus Infection

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Entecavir combined with Tenofovir Amibufenamide

## Key facts

- **NCT ID:** NCT05382351
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-10
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 238 (ESTIMATED)
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05382351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05382351, "Antiviral Therapy for Patients With Chronic Hepatitis B Infection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05382351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*